This review presents the analysis of the results of large controlled studies of the efficiency of lipid-lowering agents, disaggregants, and anti-ischemic drugs for treatment of coronary artery disease (stenocardia). It has been shown that not all preparations in one group are equally efficient. The review also adduces comparative data on the use of the listed groups of pharmaceuticals in different European countries and Russian Federation.
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/03/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/17926484